HAMILTON THORNE ANNOUNCES ANNUAL AND SPECIAL MEETING VOTING RESULTS
BEVERLY, MA and TORONTO, Ontario – June 17, 2014 – Hamilton Thorne Ltd. (TSX-V: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research market, is pleased to announce that all of the resolutions proposed at its annual general and special meeting of shareholders held on June 16, 2014 (the "Meeting") were duly passed.
At the Meeting, each of Ms. Meg Spencer and Messrs. Diarmaid Douglas-Hamilton, Dean Gendron, Bruno Maruzzo, Robert Potter, Daniel Thorne and David Wolf were elected as directors of the Company to hold office until the conclusion of the Company’s next annual general meeting or until their successors are elected or appointed. MNP LLP was also re-appointed as auditors of the Company until the close of the next annual and general meeting of shareholders or until their successors are appointed, and the directors of the Company were authorized to fix the remuneration of the auditors for the current year in such amounts as the directors may in their discretion determine.
In addition to the customary corporate matters approved at the Meeting, the Company's shareholders also approved and amendment to the Company’s existing stock option plan authorizing the Company to increase the maximum number of common shares reserved for issuance under the plan from 9,300,000 to 10,400,000, and ratifying the plan as amended.
Separately, and further to its press release of June 16, 2014, the Company wishes to provide additional information regarding the engagement of Investor Cubed Inc. (“Investor Cubed”) to provide investor relations services.
Under the terms of the engagement, Investor Cubed will initiate and maintain contact with the financial community, shareholders, investors and other stakeholders for the purposes of increasing awareness of the Company and its activities. The engagement provides for an initial term of one year but may be terminated by either party upon 60 days written notice at any time after the expiry of an initial three month period. The Company anticipates that the approximate total cost of this marketing initiative will be approximately $4,000 per month.
Investor Cubed does not have any interest, direct or indirect, in the Company or its securities, nor does Investor Cubed have any current right or intent to acquire such interest.
For further details regarding Investor Cubed please refer to the Company’s press release dated June 16, 2014, a copy of which is available under the Company’s profile on SEDAR at www.sedar.com.
About Hamilton Thorne Ltd. (www.hamiltonthorne.com)
Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced imaging systems for the fertility, stem cell and developmental biology research markets. It provides novel solutions for Life Science that reduce cost, increase productivity, improve results and enable research breakthroughs in fertility, regenerative medicine, and stem cell research markets. Hamilton Thorne's laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF procedures. Its imaging systems improve outcomes in human IVF clinics and animal breeding facilities and provide high-end toxicology analyses.
Hamilton Thorne's growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge.
Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.
Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at www.sedar.com.